Kvale G, Heuch I. Menstrual factors and breast cancer risk . Cancer . 1988;;62:1625-1631.
Brinton LA, Schairer C, Hoover RN, Fraumeni JF. Menstrual factors and risk of breast cancer . Cancer Invest . 1988;;6:245-254.
De Stavola BL, Wang DY, Allen DS, et al. The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom) . Cancer Causes Control . 1993;;4:331-340.
Negri E, LaVecchia C, Bruzzi P, et al. Risk factors for breast cancer: pooled results from three Italian case-control studies . Am J Epidemiol . 1988;;128:1207-1215.
Rautalahti M, Albanes D, Virtamo J, Palmeren J, Haukka J, Heinonen OP. Lifetime menstrual activity: indicator of breast cancer risk . Eur J Epidemiol . 1993;;9:17-25.
Bergkvist L, Adami H, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement . N Engl J Med . 1989;;321:293-297.
Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women . N Engl J Med . 1995;;332:1589-1593.
Ewertz M. Influence of non-contraceptive exogenous and endogenous hormones on breast cancer risk in Denmark . Int J Cancer . 1988;;42:832-838.
Kaufman DW, Palmer JR, de Mouzon J, et al. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study . Am J Epidemiol . 1991;;134:1375-1385.
Wingo PA, Layde PM, Lee NC, Rubin G, Ory HW. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy . JAMA . 1987;;257:209-215.
Bulbrook RD, Moore JW, Clark GMG, Wang DY. Relation between risk of breast cancer and biological availability of estradiol in the blood: prospective study in Guernsey . Ann N Y Acad Sci . 1986;;464:378-388.
Moore JW, Clark GMG, Hoare SA, et al. Binding of oestradiol to blood proteins and aetiology of breast cancer . Int J Cancer . 1986;;38:625-630.
Wysowski DK, Comstock GW, Helsing KN, Lau HL. Sex hormone levels in serum in relation to the development of breast cancer . Am J Epidemiol . 1987;;125:791-799.
Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer . Cancer Detect Prev . 1994;;18:79-85.
Garland CF, Friedlander NJ, Barrett-Connor E, Khaw K. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community . Am J Epidemiol . 1992;;135:1220-1230.
Toniolo PG, Levitz M, Zelenvich-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in post-menopausal women . J Natl Cancer Inst . 1995;;87:190-197.
Cauley JA, Gutai JP, Kuller LH, Powell JG. Reliability and interrelations among serum sex hormones in postmenopausal women . Am J Epidemiol . 1991;;133:50-57.
Eriksen EF, Colvard DS, Berg NJ, et al. Evidence of estrogen receptors in normal human osteoblast-like cells . Science . 1988;;241:84-86.
Fox KM, Magaziner J, Sherwin R, et al. Reproductive correlates of bone mass in elderly women . J Bone Miner Res . 1993;;8:901-908.
Bauer DC, Browner WS, Cauley JA, et al. Factors associated with appendicular bone mass in older women . Ann Intern Med . 1993;;118:657-665.
Jonnavithula S, Warren MP, Fox RP, Lazaro MI. Bone density is compromised in amenorrheic women despite return of menses: a 2-year study . Obstet Gynecol . 1993;;81:669-673.
Nilas L, Christiansen C. Bone mass and its relationship to age and the menopause . J Clin Endocrinol Metabol . 1987;;65:697-702.
Longcope C, Baker RS, Hui SL, Johnston CC. Androgen and estrogen dynamics in women with vertebral crush fractures . Maturitas . 1984;;6:309-318.
Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women . Ann Intern Med . 1995;;122:9-16.
Lindsay R. Hormone replacement therapy for prevention and treatment of osteoporosis . Am J Med . 1993;;95:375-395.
Cauley JA, Gutai JP, Kuller LH, Scott J, Nevitt MC. Black-white differences in serum sex hormones and bone mineral density . Am J Epidemiol . 1994;;139:1035-1046.
Cummings SR, Black DM, Nevitt MC, et al. Appendicular bone density and age predict hip Fracture in women . JAMA . 1990;;263:665-668.
Steiger P, Cummings SR, Black DM, Spencer NE, Genant HK. Age-related decrements in bone mineral density in women over 65 . J Bone Miner Res . 1992;;7:625-632.
Lohman TG, Martorell R. Anthropometric Standardization Reference Manual . Champaign, Ill: Human Kinetics Books; 1988;.
Black D, Cummings SR, Genant HK, Nevitt MC, Palermo L, Browner W. Axial and appendicular bone density predict fractures in older women . J Bone Miner Res . 1992;;7:633-638.
Kelsey JL. Breast cancer epidemiology: summary and future directions . Epidemiol Rev . 1993;;15:256-263.
Looker AC, Johnston CC, Wahner HW, et al. Prevalence of low femoral bone density in older US women from NHANES III . J Bone Miner Res . 1995;;10:796-802.
Berg RL, Cassells JS. The Second Fifty Years: Promoting Health and Preventing Disability . Washington, DC: National Academy Press; 1990;:76-100.
Muir C, Waterhouse J, Mack T, Powell J, Whelan S. Cancer Incidence in 5 Continents . Lyon, France: International Agency for Research on Cancer; 1987;.
Salamone LM, Pressman AR, Seeley DG, Cauley JA. Estrogen replacement therapy: a survey of older women's attitudes . Arch Intern Med . 1996;;156:1293-1297.
Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women . Am J Obstet Gynecol . 1990;;163:1438-1444.
Schmid C. IGF's—function and clinical importance: the regulation of osteoblast function by hormones and cytokines with special reference to insulin-like growth factors and their binding proteins . J Intern Med . 1993;;234:535-542.
Murphy LC. Antiestrogen action and growth factor regulation . Breast Cancer Res Treat . 1994;;31:61-71.
van Daele PL, Stolk RP, Burger H, et al. Bone density in non-insulin-dependent diabetes mellitus . Ann Intern Med . 1995;;122:409-414.
Cullen KJ, Smith HS, Hill S, Rosen N, Lippman ME. Growth factor messenger RNA expressing by human breast fibroblasts from benign and malignant lesions . Cancer Res . 1991;;51:4978-4985.
Ellis MJC, Singer C, Hornby A, Rasmussen A, Cullen KJ. Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer . Breast Cancer Res Treat . 1994;;31:249-261.
Persson I, Naessen T, Adami HO, et al. Reduced risk of hip fracture in women with endometrial cancer . Int J Epidemiol . 1992;;21:636-642.
Olsson H, Hagglund G. Reduced risk of morbidity and mortality in a prospective cohort of women with distal forearm fractures . Am J Epidemiol . 1992;;136:422-427.
Persson I, Adami HO, McLaughlin JK, Narssen T, Fraumeni JF. Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden) . Cancer Causes Control . 1994;;5:523-528.
Utz JP, Melton LJ III, Kan SH, Riggs BL. Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study . J Chronic Dis . 1987;;2:105-113.
Adami H, Zack M, Kressner U, et al. Hip fractures in women with breast cancer . Am J Epidemiol . 1990;;132:877-883.
Nielsen HE, Sasko P, Poulsen HS, Godeberg CC. Bone mineral content and estrogen receptors in women with breast tumors . Acta Radiol . 1985;;24:247-251.
Miller BA, Gloeckler LA, Hankey BF, et al. SEER Cancer Statistics Review, 1973-1990 . Bethesda, Md: US Dept of Health and Human Services; 1993;. National Institutes of Health publication 93-2789.
Strewler GJ, Nissenson RA. Hypercalcemia in malignancy . West J Med . 1990;;153:635-640.
Browner WS, Seeley DG, Vogt TM, Cummings SR. Non-trauma mortality in elderly women with low bone mineral density . Lancet . 1991;;338:355-358.